Business Wire

Sofinnova Partners Invests in Twentyeight-Seven Therapeutics

Share

Sofinnova Partners, a leading European venture capital firm specialized in the life sciences, today announced that the firm led Twentyeight-Seven Therapeutics, Inc’s [28-7] Series A extension with a $15 million investment. In addition to Sofinnova Partners, Osage University Partners (OUP) participated in the Series A extension bringing the total Series A financing to $82.75 million. Sofinnova Partners and OUP join the initial 28-7 investors that include MPM Capital, Novartis Venture Fund, Johnson & Johnson Innovation – JJDC, Inc., Vertex Ventures HC, Longwood Fund and Astellas Venture Management.

“Sofinnova Partners views 28-7 as the clear leader in capitalizing on the emerging science around RNA biology and how its dysregulation contributes to many serious diseases such as cancer,” said Henrijette Richter, Ph.D., Managing Partner at Sofinnova Partners. “We were captivated by the Company with its strong team of serial entrepreneurs possessing an incredible track record of successes, an exceptional group of academic founders, and the impressive scientific data and drug discovery progress around their lead RNA-focused program. They are developing game-changing therapeutics to treat cancers with high unmet need. We are therefore thrilled to be joining 28-7 early in the Company’s progress and to be investing in their exciting pipeline.” Dr. Richter will join the Company’s Board of Directors.

Since the close of the initial $65M Series A announced in September 2018, 28-7 has moved into its new facilities in Watertown, MA. Kazumi Shiosaki, Ph.D., CEO of 28-7, noted that the additional investment by Sofinnova Partners allows the Company to accelerate its current programs, build out its technology platform and expand into additional opportunities. “Sofinnova Partners is known for being a company-builder, with a strong focus on teams and science. With Sofinnova’s participation, we are able to work on proteins that regulate additional classes of RNA, including mRNA, as well as to leverage the programs into indications outside of oncology,” said Dr. Shiosaki.

28-7’s technology does not directly target small-molecules to the RNA itself but rather targets RNA-modulating proteins (RMPs). The lead program focuses on regulating levels of let-7, an important micro RNA (miRNA) that suppresses the translation of major oncogenes, whose levels can be disrupted by a protein called LIN28. In certain cancers, LIN28 is re-expressed and its binding of the let-7 precursor prevents the production of mature let-7 needed to maintain oncogene suppression. The Company's lead program is developing small molecules that prevent the binding of let-7 precursor to LIN28 and restore the beneficial levels of mature let-7.

About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together a team of professionals from all over Europe, the U.S. and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a lead or cornerstone investor in seed, start-ups, corporate spinoffs and late stage companies. It has backed nearly 500 companies over more than 45 years, creating market leaders around the globe. Today, Sofinnova Partners has over €1.9 billion under management. For more information: http://sofinnovapartners.com/.

About Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of RNA to treat cancer and other human diseases. Targeting RNA modulating proteins (RMPs), the company can use small molecules to control the expression levels of oncogenes and other proteins of significance. The company’s core technology comes from its four founding scientists, all leading researchers in RNA biology and cancer. www.twentyeight-seven.com

Contact information

Media Contact:
Kate Barrette
RooneyPartnersLLC
kbarrette@rooneyco.com
212.223.0561

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Solidifies Presence in Europe8.7.2020 06:00:00 CESTPress release

After operating under the brands Andersen Tax, Andersen Legal and Andersen Tax & Legal, the member firms of Andersen Global in Europe will now operate under a single brand, “Andersen,” demonstrating the unified and seamless approach of the global tax and legal firm. Similar brand changes in other regions around the world will follow throughout the year. This announcement comes on the heels of the U.S. member firm’s transition of its brand from “Andersen Tax” to “Andersen” last year. In total, member firms in 12 European countries—Cyprus, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, Poland, Portugal, Spain, Switzerland and the United Kingdom—will adopt the Andersen brand. The transition of OrienTax and Szabo Keleman & Partners marks the debut of the Andersen brand in Hungary. Additionally, B.A. Tax Accountants will adopt the brand as it joins the team in Luxembourg. Within Europe, Andersen Global also has a presence in Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Kazakhs

Interactive Brokers Group Opens Singapore Office8.7.2020 02:00:00 CESTPress release

Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, today announced the addition of a Singapore entity Interactive Brokers Singapore Pte Ltd and the opening of an office located in the Marina Bay Financial District. With the addition of Singapore, the global brokerage firm now has nine entities around the globe in the US, Australia, Canada, Hong Kong, India, Japan, Luxembourg and the UK, serving over 876,000 clients accounts in more than 220 countries and territories. “As our client base continues to rapidly increase in Singapore, it was important to create a presence on the ground to support and service active traders and the wealth management community,” said David Friedland, Managing Director of the Asia Pacific region for Interactive Brokers. “As a critical wealth management and financial hub in Asia, our expansion in the region reflects that importance and keeps up with account growth.” Over 37% of Interactive Brokers accounts now come from Asia, up from 27% in 2017

Mary Kay Inc. Continues Its Support of Beauty, Fashion, and Design in Events Held Across Asia, Europe and the U.S.8.7.2020 00:10:00 CESTPress release

Mary Kay Inc. and its Mary Kay Global Design Studio, recently sponsored and participated in various beauty, fashion and design events around the world with the aim of promoting the art of individual and unique beauty—and beauty artists themselves—setting the stage for the upcoming trends for the season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200707005913/en/ Mary Kay beauty experts were on hand to tailor looks before the 27th Czech Lion Awards Show (Photo: Mary Kay) Glamhive Live & Glamhive Digital Summer Bazaar Mary Kay was the presenting sponsor for the inaugural Glamhive Live Digital Summit on May 9. Glamhive, a startup digital fashion company founded by celebrity stylist Stephanie Sprangers, allows users to receive straight-forward virtual advice from expert stylists around the world. Glamhive stylists include Tara Swennen, Ilaria Urbinati, Nicole Chavez, Jeanne Yang, Samantha McMillen, Sonia Young, Micah Schifma

FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product7.7.2020 20:47:00 CESTPress release

Regulatory News: The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health. - Today’s decision demonstrates that IQOS is a fundamentally different tobacco product and a better choice for adults who would otherwise continue smoking - IQOS is the first and only electronic nicotine product to be granted marketing orders through the FDA’s MRTP process - The FDA authorized the marketing of IQOS with the following information: - The IQOS System heats tobacco but does not burn it - This significantly reduces the production of harmful and potentially harmful chemicals - Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system reduces your body’s exposure to harmful or potentially harmful chemical

Interactive Brokers Group to Host Second Quarter Earnings Conference Call7.7.2020 15:00:00 CESTPress release

Interactive Brokers Group, Inc. (Nasdaq: IBKR) plans to announce its second quarter financial results on Tuesday, July 21, 2020, in a release that will be issued at approximately 4:00 pm (ET). The press release will also be available on the company's website, www.interactivebrokers.com/ir. A conference call to discuss the company's results will be held at 4:30 pm (ET) on that day, July 21. Members of the public who would like to listen to the conference call should dial 877-324-1965 (U.S. domestic) or 631-291-4512 (international). The number should be dialed approximately ten minutes prior to the start of the conference call. The conference call will also be accessible as an audio webcast through the Investor Relations section of the Interactive Brokers website, www.interactivebrokers.com/ir. About Interactive Brokers Group, Inc.: Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities and foreign exchange around the clock on over 1

Virtual Esri User Conference to Explore How GIS Interconnects the World7.7.2020 14:41:00 CESTPress release

Esri, the global leader in location intelligence, today announced that the 40th annual Esri User Conference will be the largest virtual gathering of GIS professionals. Normally held in San Diego, California, the conference will be presented in a completely virtual format and take place July 13–16, 2020. The Esri User Conference brings together technology innovators, executives, educators, scientists, and GIS users seeking to solve challenges in their organizations and throughout the world, using the most powerful mapping and analytics platform on the planet. This year's conference theme, GIS—Interconnecting Our World, explores how geospatial technology can integrate everything and engage everyone to overcome unprecedented global challenges. Esri founder and president Jack Dangermond will open the conference—which this year will see the Plenary Session span across three days—with his observations on how GIS, the world's nervous system, has never been more interconnected than it is today